真实世界人群中2型糖尿病诊断前后BMI轨迹
该研究利用苏格兰糖尿病协作数据库的电子病历,纳入2736例个体,计算诊断前3年至前6个月及诊断后1至5年的BMI轨迹。诊断前71%个体体重增加,诊断后63%个体体重下降;诊断前体重变化与诊断后体重变化无关。诊断后体重下降与年龄较大、女性、较高BMI、较高HbA1c及围诊断期体重增加相关。诊断时高HbA1c但随后快速减重并接受最积极治疗者5年血糖控制最佳。
要点
- 诊断前71%个体体重增加,32%个体每年增加超过0.5 kg/m²。
- 诊断后63%个体体重下降;诊断前体重变化与诊断后体重变化无关。
- 诊断时高HbA1c、快速减重且1年时治疗最积极者5年血糖控制最佳。
核心结论
- 诊断前平均体重增加、诊断后平均体重下降,但人群内体重变化存在显著差异。
- 年轻个体诊断前体重增加,而老年人2型糖尿病与体重增加关联较小,符合老年糖尿病病因的其他驱动因素。
- 诊断时高HbA1c并非必然与不良结局相关,可能由可逆的糖毒性驱动。
研究设计与样本
- 观察性队列研究,使用苏格兰糖尿病协作数据库的电子病历。
- 基于诊断前3年至前6个月及诊断后1至5年的BMI测量值计算两个轨迹。
- 诊断后轨迹中每个BMI测量值对糖尿病药物和HbA1c变化效应进行时间依赖调整。
- 共纳入2736例个体。
主要发现
- 诊断前体重增加模式:1944例(71%)个体总体增重,875例(32%)个体每年增重超过0.5 kg/m²。
- 诊断后体重下降模式:1722例(63%)个体体重下降。
- 较年轻年龄和较大社会剥夺与诊断前体重增加增加相关。
- 诊断前体重变化与诊断后体重变化无关。
- 诊断后体重下降与年龄较大、女性、较高BMI、较高HbA1c及围诊断期体重增加相关。
关键数值与推荐
- 围诊断期定义为诊断前6个月至诊断后12个月。
- 共986例(36%)个体在诊断时高HbA1c、快速减重且1年时治疗最积极,该亚组5年血糖控制最佳。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Few studies have examined the clinical characteristics associated with changes in weight before and after diagnosis of type 2 diabetes. Using a large real-world cohort, we derived trajectories of BMI before and after diabetes diagnosis, and examined the clinical characteristics associated with these trajectories, including assessing the impact of pre-diagnosis weight change on post-diagnosis weight change. METHODS: We performed an observational cohort study using electronic medical records from individuals in the Scottish Care Information Diabetes Collaboration database. Two trajectories were calculated, based on observed BMI measurements between 3 years and 6 months before diagnosis and between 1 and 5 years after diagnosis. In the post-diagnosis trajectory, each BMI measurement was time-dependently adjusted for the effects of diabetes medications and HbA1c change. RESULTS: A total of 2736 individuals were included in the study. There was a pattern of pre-diagnosis weight gain, with 1944 individuals (71%) gaining weight overall, and 875 (32%) gaining more than 0.5 kg/m2 per year. This was followed by a pattern of weight loss after diagnosis, with 1722 individuals (63%) losing weight. Younger age and greater social deprivation were associated with increased weight gain before diagnosis. Pre-diagnosis weight change was unrelated to post-diagnosis weight change, but post-diagnosis weight loss was associated with older age, female sex, higher BMI, higher HbA1c and weight gain during the peri-diagnosis period. When considering the peri-diagnostic period (defined as from 6 months before to 12 months after diagnosis), we identified 986 (36%) individuals who had a high HbA1c at diagnosis but who lost weight rapidly and were most aggressively treated at 1 year; this subgroup had the best glycaemic control at 5 years. CONCLUSIONS/INTERPRETATION: Average weight increases before diagnosis and decreases after diagnosis; however, there were significant differences across the population in terms of weight changes. Younger individuals gained weight pre-diagnosis, but, in older individuals, type 2 diabetes is less associated with weight gain, consistent with other drivers for diabetes aetiology in older adults. We have identified a substantial group of individuals who have a rapid deterioration in glycaemic control, together with weight loss, around the time of diagnosis, and who subsequently stabilise, suggesting that a high HbA1c at diagnosis is not inevitably associated with a poor outcome and may be driven by reversible glucose toxicity.
引用
- Donnelly LA, McCrimmon RJ, Pearson ER, et al. Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population. Diabetologia. 2024. PMID: 38967665. doi:10.1007/s00125-024-06217-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。